Association of Postoperative Hypoglycemia With Mortality After Elective Craniotomy.

BACKGROUND AND OBJECTIVES: Hypoglycemia is a known risk of intensive postoperative glucose control in neurosurgical patients. However, the impact of postoperative hypoglycemia after craniotomy remains unexplored. This study aimed to determine the association between postoperative hypoglycemia and mortality in patients undergoing elective craniotomy. METHODS: This study involved adult patients who underwent elective craniotomy at the West China Hospital, Sichuan University, between January 2011 and March 2021. We defined moderate hypoglycemia as blood glucose levels below 3.9 mmol/L (70 mg/dL) and severe hypoglycemia as blood glucose levels below 2.2 mmol/L (40 mg/dL). The primary outcome was postoperative 90-day mortality. RESULTS: This study involved 15 040 patients undergoing an elective craniotomy. Overall, 504 (3.4%) patients experienced moderate hypoglycemia, whereas 125 (0.8%) patients experienced severe hypoglycemia. Multivariable analysis revealed that both moderate hypoglycemia (adjusted odds ratio [aOR] 1.86, 95% CI 1.24-2.78) and severe (aOR 2.94, 95% CI 1.46-5.92) hypoglycemia were associated with increased 90-day mortality compared with patients without hypoglycemia. Moreover, patients with moderate (aOR 2.78, 95% CI 2.28-3.39) or severe (aOR 16.70, 95% CI 10.63-26.23) hypoglycemia demonstrated a significantly higher OR for major morbidity after adjustment, compared with those without hypoglycemia. Patients experiencing moderate (aOR 3.20, 95% CI 2.65-3.88) or severe (aOR 14.03, 95% CI 8.78-22.43) hypoglycemia had significantly longer hospital stays than those without hypoglycemia. The risk of mortality and morbidity showed a tendency to increase with the number of hypoglycemia episodes in patients undergoing elective craniotomy (P for trend = .01, <.001). CONCLUSION: Among patients undergoing an elective craniotomy, moderate hypoglycemia and severe hypoglycemia are associated with increased mortality, major morbidity, and prolonged hospital stays. In addition, the risk of mortality and major morbidity increases with the number of hypoglycemia episodes.

Predictors of mortality after craniotomy for geriatric traumatic brain injury.

BACKGROUND: With a sustained increase in the proportion of elderly trauma patients, geriatric traumatic brain injury (TBI) is a significant source of morbidity, mortality and resource utilization. The aim of our study was to assess the predictors of mortality in geriatric TBI patients who underwent craniotomy. METHODS: We performed a 4-year analysis of ACS-TQIP database (2016-2019) and included all geriatric trauma patients (≥65y) with isolated severe TBI who underwent craniotomy. We calculated 11- point modified frailty index (mFI) for patients. Our primary and secondary outcomes were mortality and unfavorable outcome, respectively. Multivariate regression analysis was performed to identify the predictors of outcomes. Patients with mFI ≥ 0.25 were defined as Frail, whereas patient with mFI of 0.08 or higher (<0.25) were identified as pre-frail; Non-frail patients were identified as mFI of <0.08. RESULTS: We analyzed data from 20,303 patients. The mortality rate was 17.7 % (3,587 patients). Having ≥ 2 concomitant types of intra-cranial hemorrhage (OR = 2.251, p < 0.001), and pre-hospital anticoagulant use (OR = 1.306, p < 0.001) increased the risks of mortality. Frailty, as a continuous variable, was not considered as a risk factor for mortality (p = 0.058) but after categorization, it was shown that compared to non-frails, patients with pre-frailty (OR = 1.946, p = 0.011) and frailty (OR = 1.786, p = 0.026) had increased risks of mortality. Higher mFI (OR = 4.841), age (OR = 1.034), ISS (OR = 1.052), having ≥ 2 concomitant types of intra-cranial hemorrhage (OR = 1.758), and use of anticoagulants (OR = 1.117) were significant risk factors for unfavorable outcomes (p < 0.001, for all). CONCLUSIONS: Having more than two types of intra-cranial hemorrhage and pre-hospital anticoagulant use were significant risk factors for mortality. The study's findings also suggest that frailty may not be a sufficient predictor of mortality after craniotomy in geriatric patients with TBI. However, frailty still affects the discharge disposition and favorable outcome. LEVEL OF EVIDENCE: Level III retrospective study.

Preoperative prescription opioid use as an independent predictor of 90-day mortality and adverse events in craniotomy and craniectomy patients.

OBJECTIVE: A growing body of literature suggests that preoperative opioid exposure is an independent predictor of poor outcomes in surgical patients. No outcomes data exist on preoperative opioid use and craniotomies/craniectomies. The objective of this study was to determine the impact of preoperative opioid use on 90-day adverse events after craniotomy or craniectomy. METHODS: A single-center retrospective cohort study of 2445 patients undergoing a craniotomy/craniectomy between January 1, 2013, and October 1, 2018, was conducted. Baseline demographics, pre- and postoperative opioid use (morphine milligram equivalents [MMEs]), and surgical metrics were recorded. Patients were categorized based on whether they took prescription opioids preoperatively, defined as within 1 month of surgery, or were opioid naive. The outcomes were mortality and adverse events 90 days after craniotomy/craniectomy. RESULTS: Overall, 26.6% of patients composed the preoperative opioid group. The median daily MME intake among this group was 34.6 (IQR 14.1-90) MMEs. Lower employment rates (p < 0.001), uninsured status (p = 0.016), and intravenous drug use (p = 0.006) were associated with preoperative opioid use. Preoperative opioid use was associated with increased venous thromboembolism (p = 0.001), acute kidney injury (p = 0.002), acute respiratory failure (p < 0.001), myocardial infarction (p = 0.002), delirium (p < 0.001), and infection (p < 0.001). Preoperative opioid use was an independent predictor of overall 90-day adverse events (OR 1.643, 95% CI 1.289-2.095; p < 0.001) and 90-day mortality (OR 1.690, 95% CI 1.254-2.277; p < 0.001). CONCLUSIONS: Preoperative opioid use was independently associated with 90-day postoperative adverse events and mortality. Opioid use increases vulnerability in craniotomy/craniectomy patients and necessitates close monitoring to improve outcomes.

The extended pterional approach allows excellent results for removal of anterior cranial fossa meningiomas / O acesso pterional extendido permite excelente resultado para a ressecção dos meningiomas da fossa craniana anterior

ABSTRACT Objective To describe a unique operative strategy, instead the classical pterional approach, and to analyses it safety and effectiveness for removal of anterior cranial fossa meningiomas. Method We identify 38 patients with tuberculum sellae and olphactory groove meningiomas operated between 1986 and 2013. Medical charts, operative reports, imaging studies and clinical follow-up evaluations were reviewed and analyzed retrospectively. The pterional craniotomy is extended toward the frontal bone providing access through the subfrontal route, besides the usual anterolateral view provided by the classical pterional approach. Results Surgical mortality occurred in one patient (2.6%). Gross total resection was achieved in 27 patients (86.8%). Median time of follow-up was 69.4 months. Conclusion The extended pterional approach allows excellent results. Total removal of meningiomas of the anterior cranial fossa was obtained in 86.8 % of patients, with low morbidity and mortality.

RESUMO Objetivo Descrever a craniotomia pterional estendida, ao invés da abordagem pterional clássica, e analisar sua segurança e eficácia para a remoção dos meningiomas da fossa anterior. Método Identificamos 38 pacientes com meningiomas do tubérculo da sela e da goteira olfatória operados entre 1986 e 2013. Os prontuários, relatórios cirúrgicos, exames de imagem e acompanhamento pós-operatório foram analisados retrospectivamente. A craniotomia pterional com extensão para o osso frontal permite acesso pela via subfrontal além da via anterolateral do acesso pterional clássico. Resultados A mortalidade cirúrgica foi de 2,6% (um paciente). A remoção total foi alcançada em 86,8% (27 pacientes) com um tempo médio de seguimento de 69,4 meses. Conclusão A abordagem pterional estendida permite excelentes resultados. A remoção total dos meningiomas da fossa craniana anterior foi obtida em 86,8% dos pacientes, com baixa morbi-mortalidade.

Experiencia obtenida con el uso de la craniectomía descompresiva en el hospital de urgencia Asistencia Pública de Santiago / Experience with the use of decompressive craniectomy in the hospital emergency Santiago Public Assistance

Se revisaron 24 pacientes sometidos a craniectomía descompresiva en el HUAP entre los años 2009 y 2011, constituyendo el 8 por ciento de las cirugías realizadas en ese período. La distribución por edad fue mayoritariamente en el sexo masculino con un 75 por ciento de los pacientes. No se encontró clara relación en el outcome en relación a la edad y al Glasgow de ingreso. El mecanismo causal más frecuente fueron los atropellos con un 60,87 por ciento de los casos, seguido por las caídas con un 26,09 por ciento y las agresiones con un 13,04 por ciento. Se consignó la presencia de alcohol en al menos 29,16 por ciento de los enfermos. La mortalidad registrada fue de un 45,83 por ciento versus una sobrevida de un 54,17 por ciento. De los pacientes vivos, un 33,77 por ciento egresó autovalente, un 46,15 por ciento quedó dependiente y un 23,08 por ciento quedó en estado vegetativo. En las causas de mortalidad se encontró una alta tasa secundaria a infecciones respiratorias con un 45,45 por ciento del total de los decesos. La tasa de complicaciones postoperatorias fue del orden de un 45,83 por ciento, requiriendo de resolución quirúrgica el 63,3 por ciento de ellas. Hubo un mejor outcome en los pacientes en que la craniectomía se realizó dentro de las 1ras 24 horas versus las efectuadas en forma diferida. Las complicaciones más frecuentes fueron las colecciones yuxtadurales, seguidas de las complicaciones infecciosas.

Acesso subcranial minimamente invasivo: alternativa cirúrgica para ressecção de tumores da base do crânio anterior / Minimally invasive subcranial approach: a surgical alternative for the ressection of anterior skull base tumors

Objetivo: descrever e anlisar nossa experiência em ressecção de tumores craniofaciais através de um acesso subcranial modificado, minimamente invasivo, desenvolvido por nós. Pacientes e método: estudo prospectivo com 26 pacientesapresentando tumores pequenos na base do crânio anterior, trtados nas Seções de Cirurgia de Cabeça e Pescoço e de Neurocirurgia do INCA-MS-RJ, no período de março de 2000 a setembro de 2006, operados pela mesma equipe cirúrgica, utilizando a técnica inovadora subcranial minimamente invasiva. Comparamos nossos resultados com resultados já publicados em literatura dos nossos pacientes submetidos à cirurgia craniofacial clássica, assim como com dados de literatura mundia. Resultados: dos 26 pacientes, 14 eram do gênero masculino. A idade média foi de 45,7 anos. O acesso subcranial isolado sem incisões faciais foi utilizado em seis casos. O tempo cirúrgico médio foi de 8,38 horas. A média de internação na unidade de terapia intensiva foi de 1,2 dias e de internação hospitalar de 7,8 dias. Não observamos complicações neurológicas imediatas. O índice de complicações foi de 28,5% com mortalidade operatória nula. A sobrevida global (para tumores malignos) foi de 61,9%. Conclusão: trata-se de um acesso inovador, onde podemos observar alguns benefícios notáveis, como a redução de complicações neurológicas gerais, tendência a reduzir o tempo cirúrgico, baixa taxa de hemotransfusão, menor tempo de internação em terapia intensiva e hospitalar e praticabilidade para tumores faciais acometendo o platô cribiforme ou discreta invasão da fossa craniana anterior.

Objective: to describe and to analyze our experience with the resection of craniofacial tumors throughe a modified minimally invasive subcranial access, developed by us. Patients and methods: prospective study with 26 patients presenting small tumors in the anterior skull base, treated in the Section of Head and Neck Surgery and Neurosurgery (INCA-MS-RJ), in the period from March, 2000 to September, 2006. The same surgical team was responsible for all surgeries using the innovative minimally invasive surgical technique. We compare the results of this technique with the results already published in the literature of our own patients treated by the classic cranialfacial technique, as well as, with data of worldwide literature. Results: of the 26 patients, 14 were men. The average age was of 45.7. The isolated subcranial access without face incisions was employed in 6 cases. The average surgical time was of 8.38h. The average stay in the intensive care unit was 1.2 days and the hospitalization time was 7.8 days. We did not observe immediate neurological complications. The complications incidence was 28.5%, without surgical death. The overall survival rate was 61.9% for malignant tumors. Conclusion: this is an innovative surgical approach in which we could observe some notables benefits, such as the reduction of neurological and general complications, trend to reduce to reduce the surgical time, low tax of hemotransfusion, minor time of stay under intensive care and in the hospital, and practicability for facial tumors resection, involving the cribriform plate or small invasion of the anterior skull base.

Hematoma subdural crônico: análise de 35 casos / Chronic subdural hematoma: analysis of 35 cases

Os autores relatam 35 casos com diagnóstico de hematoma subdural crônico, operados no período de janeiro-1988 a março-1995. A idade dos pacientes variou entre 19 e 80 anos. Foram eles agrupados retrospectivamente segundo a escala de Bender. Quanto ao tratamento cirúrgico, foram empregadas duas técnicas: craniotomia com membranectomia e dupla trepanaçao com instilaçao de soluçao salina na cavidade ocupada pelo hematoma. O índice de mortalidade entre os pacientes submetidos à craniotomia foi 16,6 por cento e nos pacientes submetidos à trepanaçao foi nulo. Dentre os pacientes que faleceram, 80 por cento encontravam-se em grau III ou IV na escala de Bender. O hematoma subdural crônico apresenta até os dias atuais alguns aspectos controversos, como quanto à sua fisiopatologia e ao tratamento cirúrgico adequado.